Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
10.50
-0.76 (-6.75%)
At close: Oct 2, 2026, 4:00 PM EDT
10.50
0.00 (0.00%)
After-hours: Oct 2, 2026, 4:16 PM EDT
Monte Rosa Therapeutics Market Cap
Monte Rosa Therapeutics has a market cap or net worth of $895.79 million as of October 2, 2026. Its market cap has increased by 93.39% in one year.
Market Cap
895.79M
Enterprise Value
312.67M
1-Year Change
93.39%
Ranking
Category
Stock Price
$10.50
ChartMarket Cap Chart
Since the IPO on June 24, 2021, Monte Rosa Therapeutics's market cap has increased from $845.31M to $895.79M, an increase of 5.97%. That is a compound annual growth rate of 1.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 895.79M | -12.27% |
| Dec 31, 2025 | 1.02B | 139.48% |
| Dec 31, 2024 | 426.37M | 50.74% |
| Dec 29, 2023 | 282.85M | -23.21% |
| Dec 30, 2022 | 368.32M | -61.22% |
| Dec 31, 2021 | 949.65M | 12.34% |
| Jun 24, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aktis Oncology | 1.08B |
| Seaport Therapeutics | 1.08B |
| Odyssey Therapeutics | 1.06B |
| MeiraGTx Holdings | 1.06B |
| Janux Therapeutics | 1.06B |
| Adlai Nortye Group | 1.03B |
| Alto Neuroscience | 1.00B |
| MoonLake Immunotherapeutics | 995.75M |